Capital Counsel LLC Moderna, Inc. Transaction History

Capital Counsel LLC

$2.18 Billion
Q1 2024

A detailed history of Capital Counsel LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Capital Counsel LLC holds 9,970 shares of MRNA stock, worth $1.18 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

9,970

Previous 10,401 4.14%

Holding current value

$1.18 Million

Previous $1.03 Million 2.71%

% of portfolio

0.05%

Previous 0.05%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$85.37 - $115.44 $36,794 - $49,754	-431 Reduced 4.14%	9,970 $1.06 Million
Q4 2023 Feb 14, 2024	SELL	$69.51 - $104.43 $11,816 - $17,753	-170 Reduced 1.61%	10,401 $1.03 Million
Q3 2023 Nov 13, 2023	BUY	$96.41 - $126.61 $226,852 - $297,913	2,353 Added 28.63%	10,571 $1.09 Million
Q1 2023 May 15, 2023	BUY	$135.66 - $197.02 $61,047 - $88,659	450 Added 5.79%	8,218 $1.26 Million
Q4 2022 Feb 09, 2023	BUY	$118.38 - $210.04 $2,485 - $4,410	21 Added 0.27%	7,768 $1.4 Million

Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $3,542 - $5,825	30 Added 0.39%	7,747 $916,000
Q2 2022 Aug 15, 2022	BUY	$117.13 - $176.59 $2,811 - $4,238	24 Added 0.31%	7,717 $1.1 Million
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $758 - $1,410	-6 Reduced 0.08%	7,693 $1.33 Million
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $20,549 - $33,534	-91 Reduced 1.17%	7,699 $1.96 Million
Q3 2021 Nov 12, 2021	SELL	$221.9 - $484.47 $11,095 - $24,223	-50 Reduced 0.64%	7,790 $3 Million
Q2 2021 Aug 12, 2021	SELL	$129.91 - $234.98 $23,383 - $42,296	-180 Reduced 2.24%	7,840 $1.84 Million
Q1 2021 May 12, 2021	BUY	$109.18 - $185.98 $875,623 - $1.49 Million	8,020 New	8,020 $1.05 Million

Others Institutions Holding MRNA

# of Institutions

1,036

Shares Held

245M

Call Options Held

12.1M

Put Options Held

9.36M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $46.5B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Counsel LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Counsel LLC with notifications on news.

Account

Capital Counsel LLC Moderna, Inc. Transaction History